A comparison of HLA-B*15:02 screening tests before prescribing carbamazepine

Publish : March 15, 2014
Total Download : 1

A comparison of HLA-B*15:02 screening tests before
prescribing carbamazepine

Jaruthamsophon K, Limprasert P

Department of Pathology, Faculty of Medicine, Prince of Songka Unisersity, Songkhla, Thailand

Introduction: HLA-B*15:02 is the most significant biomarker associated with carbamazepine-induced severe cutaneous drug reaction in Asians. A number of HLA-B*15:02 screening tests have been developed to prevent the drug reaction in clinical practice. However, no comparison of these methods has to date been reported.

Download

Address of editorial Corresponce
✎  Vorachai Sirikulchayanonta, MD, Editor-in-Chief: Asian Archives of Pathology, Faculty of Science, Rangsit University, Pathumthani 12000, Thailand.
✉  Email address: asianarchpath@gmail.com, vorachai7@gmail.com